Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report-Reference-Cited by-同舟云学术

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

Published:2019-03 Issue:3 Volume:22 Page:267-275
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Brazier John,Ara Roberta,Azzabi Ismail,Busschbach Jan,Chevrou-Séverac Hélène,Crawford Bruce,Cruz Luciane,Karnon John,Lloyd Andrew,Paisley Suzy,Pickard A. Simon

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference40 articles.

1. How health state utilities used in cost-effectiveness models are currently identified, reviewed and reported;Ara;Value Outcomes Spotlight,2018

2. Population norms for the EQ-5D;Janssen,2014

3. A comparison of the EQ-5D and SF-6D across seven patient groups;Brazier;Health Econ,2004

4. Why do multi-attribute utility measure produce different utilities: the relative importance of the descriptive systems, scale and “micro-utility” effects;Richardson;Qual Life Res,2015

5. Utility values in National Institute for Health and Clinical Excellence (NICE) technology appraisals;Tosh;Value Health,2011

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States;Value in Health;2024-02

2. The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health-Related Quality of Life;PharmacoEconomics;2024-01-13

3. International Systematic Review of Utility Values Associated with Cardiovascular Disease and Reflections on Selecting Evidence for a UK Decision-Analytic Model;Medical Decision Making;2024-01-04

4. Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients;Medicina;2023-12-24

5. Surgical prioritization based on decision model outcomes is not sensitive to differences between the health-related quality of life values estimates of physicians and citizens;Quality of Life Research;2023-11-08